Back to event list
Buprenorphine Waiver Training - OB/GYN Focus
This FREE course educates physicians, nurse practitioners, and physician assistants on prescribing buprenorphine for the treatment of opioid use disorder, with particular attention to the treatment of women during pregnancy and postpartum. SNOW DATE: March 16.
This eight-hour course prepares physicians, nurse practitioners, and physician assistants to prescribe buprenorphine to treat opioid use disorder in their office, with a focus on the treatment of pregnant and postpartum women. The course also fulfills waiver training requirements for providers who do not specialize in OB/GYN care. The curriculum includes the science of addiction as a brain disorder, the pharmacology of buprenorphine, and the regulatory requirements around prescribing this medication. In addition to addressing the management of buprenorphine treatment in the general population, particular attention will be devoted to the special considerations involved in treating opioid use disorder during pregnancy. Attendees will learn to screen patients for treatment with buprenorphine and to manage the medication along with the patient's other medical needs in an office setting such as a primary care clinic. The course fulfills 8 hours of the training needed to obtain a waiver to prescribe buprenorphine. The Drug Addiction Treatment Act of 2000 (DATA 2000) requires physicians to complete 8 hours of approved training in order to be eligible for a waiver, and nurse practitioners and physician assistants to complete 24 hours.
DAY OF Contact:
Colleen LaBelle; Colleen.Labelle@bmc.org; 617-797-6712
Check-in for the course will be from 7:30 to 8:00 am and the training will run from 8:00 am to 4:00 pm.
Breakfast and lunch will be provided.
This is an in-person training. There will not be an option to attend via webinar.
Upon completion of this training, the participants will (be able to):
Have the training required to apply for a waiver to prescribe buprenorphine to their patients with opioid dependence (addiction),
Identify and assess patients who are appropriate for treatment with buprenorphine,
Have the specific knowledge concerning the use of buprenorphine to manage opioid dependence in the outpatient setting,
Discuss the psychiatric and medical co-morbidities associated with opioid addiction.
Physicians (MD, DO), Nurse Practitioners, and Physician Assistants
PCSS Physician Clinical Support System, Boston Medical Center (BMC), Massachusetts Department of Public Health (DPH), American Academy of Addiction Psychiatry (AAAP), and the Massachusetts Bureau of Substance Abuse Services (BSAS).
This program has no commercial support. Faculty and planners have no vested interests and there are no conflicts of interest. There will be no discussion of off label uses of drugs.
Boston Medical Center is an approved provider of continuing nursing education by American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
AMA Credit Designation Statement
American Academy of Addiction Psychiatry (AAAP) designates this live educational activity for a maximum of 8 (eight)
AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Funding for this initiative was made possible (in part) by Providers Clinical Support System for Medication Assisted Treatment (5U79TI024697) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Eligible attendees will be able to obtain CMEs from AAAP after the event takes place.